In T1D, dysregulated TRPV1 signaling contributes to cognitive decline, anxiety, altered satiety, and central autonomic failure—positioning TRPV1 as both a mechanistic link and therapeutic target in managing CNS manifestations of autoimmune diabetes. Here, TRPV1 is linked to Anxiety.